Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors

NACompletedINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

March 7, 2016

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Breast Cancer
Interventions
BEHAVIORAL

MBSR(BC) 6 Week Program

The MBSR(BC) is a clinical program that provides systematic training to promote stress reduction by self-regulating arousal to stress. The goal of training is to teach participants to become more aware of their thoughts and feelings, and through meditation practice, to have the ability to step back from thoughts and feelings during stressful situations that contribute to increased emotional distress. It incorporates simple yoga, sitting meditation, body scan, and walking meditation in this program. Classes for this intervention occur on a weekly basis for 2 hours for 6 weeks. The participants will be asked to record their informal/formal practices in a daily diary during the program and from 6 weeks to 6 months after the intervention.

BEHAVIORAL

BCES 6 Week Program

"The BCES is an education support program. This 6-week program is based on the published NIH program, Support for People with Cancer: Taking Time Education Support Group. In addition the class sessions consist of group discussion of educational materials and homework assignments; and group processes related to sharing supportive care situations. The participants will record their feelings, coping mechanisms, and questions related to survivorship in a daily diary during the program and from 6 weeks to 6 months after the intervention."

Trial Locations (5)

33612

Moffitt Cancer Center, Tampa

University of South Florida, Tampa

USF Health Carol and Frank Morsani Center, Tampa

33613

Florida Hospital Tampa, Tampa

34239

Sarasota Memorial Hospital, Sarasota

All Listed Sponsors
lead

University of South Florida

OTHER

NCT02786797 - Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors | Biotech Hunter | Biotech Hunter